The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

Pancreatic cancer is on the rise in the United States, but there's another, less common type called pancreatic neuroendocrine ...

Theriva announced that a second Independent Data Monitoring Committee review of data from the VIRAGE Phase 2b clinical trial in newly-diagnosed ...

EXEL announced that the FDA has approved the label expansion of its lead drug Cabometyx (cabozantinib). The regulatory body approved Cabometyx for the treatment of adult and pediatric patients 12 ...

Exelixis, Inc. (Nasdaq: EXEL) today announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX® (cabozantinib) for the treatment of 1) adult and pediatric patients 12 years of ...

More and more people are being diagnosed with pancreatic cancer. This disease is insidious, often only making itself known in ...

Introduction: Pancreatic adenocarcinoma (PAAD) is characterized by a profoundly immunosuppressive tumor microenvironment (TME) that limits the efficacy of immunotherapy. Emerging evidence suggests ...

CINCINNATI (WKRC) — Researchers are conducting a groundbreaking trial that could revolutionize the way the body fights cancer, particularly for those living with pancreatic cancer. This trial is ...

GAINESVILLE, Fla. — Smoking isn’t the only lifestyle choice that might be damaging your lungs. Scientists have uncovered a surprising new villain in the fight against lung cancer: the combination of ...

Pancreatic cancer remains one of the most formidable cancers due to its insidious nature. In its initial stages, it rarely causes noticeable symptoms, making early diagnosis incredibly challenging.

The Las Vegas Raiders got to work to start the free agency period, catching some attention with a few of their moves. As several media outlets publish their grades for each NFL team's free agency ...

Adding immunotherapy to new KRAS inhibitors boosted responses in preclinical models, setting the stage for future trials of the combination strategy. Adding immunotherapy to a new type of ...